Virtual Roundtable on Diversity in Clinical Trial Enrollment


The Society for Immunotherapy of Cancer (SITC) invites you to attend the virtual Roundtable on Diversity in Clinical Trial Enrollment.

The goal of the roundtable is to develop recommendations for specific actions each stakeholder in the clinical trial ecosystem can take to positively impact diversity in clinical trial enrollment. Representatives from each stakeholder group will participate in the roundtable, which will consist of a series of presentations and panels that highlight success stories and lessons learned in addressing implicit bias challenges, creating patient and community engagement and optimizing trial designs and operations that facilitate access to clinical trials for patients of diverse backgrounds. By enabling a conversation across stakeholders, SITC aims to carve a roadmap for next steps each stakeholder group can take to increase diversity in all immuno-oncology clinical trials.


Roundtable Agenda

Tuesday, July 25  |  3–6:10 p.m. ET

Welcome

3:00–3:15 p.m.

Leisha A. Emens, MD, PhD
Ankyra Therpeutics

Setting the Stage

3:15–4:25 p.m.

Moderator
Leisha A. Emens, MD, PhD

Ankyra Therpeutics


3:15–3:30 p.m.

Patient Perspective
Mel Mann, MBA, MEd

3:30–3:45 p.m. 

Implicit Bias 
Mona Fouad, MD, MPH
University of Alabama at Birmingham

3:45–4:05 p.m.

Success Story - Sponsor Perspective 
Shalini Mohan, MD
Genentech

4:05–4:25 p.m.

Success Story - Community Perspective
Augusto Ochoa, MD
Louisiana State University Health Sciences Center

Panel 1

4:25–4:55 p.m.

Implicit Bias: Broadening the Lens

Panel 2

4:55–5:25 p.m

Patient and Community Engagement

Panel 3

5:25–5:55 p.m. 

Trial Complexity vs. Standard of Care

Summary & Next Steps

5:55–6:10 p.m.

Leisha A. Emens, MD, PhD
Ankyra Therpeutics

Virtual Roundtable Organizers


Leisha A. Emens, MD, PhD

Ankyra Therapeutics 


Chelsea C. Pinnix, MD, PhD

The University of Texas MD Anderson Cancer Center


Padmanee Sharma, MD, PhD

The University of Texas MD Anderson Cancer Center

John H. Stewart IV, MD, MBA, FACS


John H. Stewart IV, MD, MBA, FACS

LSU-LCMC Health Cancer Center